Elidah

What Elidah does

Elidah Inc. is a privately held medical device company founded in 2014/2015 by biomedical engineer Gloria Kolb, headquartered in Monroe, Connecticut. The company develops and sells the Elitone platform of FDA-cleared, external (non-vaginal, non-invasive) neuromuscular stimulation devices for the treatment of urinary incontinence. Its core technology centers on a proprietary Pre-Modulated Waveform (PMW) delivered through a patented perineal GelPad with four conductive regions, enabling electrical stimulation to reach pelvic floor muscles through the skin without internal probes. The product portfolio comprises Elitone for stress and mixed urinary incontinence, Elitone URGE for overactive bladder, and Elitone for Men for post-prostatectomy incontinence, with companion GelPad consumables and accessories.

Elidah operates a primarily direct-to-consumer go-to-market model through its e-commerce site (elitone.com), supplemented by retail distribution via CVS Pharmacy, a Medicare Part B billing pathway enabled through a telehealth partnership with MD Integrations, clinician office sales, and a 2025 distribution partnership with women's-health platform FEMSelect. The Starter Kit is priced at $429 and the Bundle at $539, with recurring revenue from GelPad refill packs at $33 for a pack of five; Medicare-eligible patients can access treatment at a co-pay as low as $11-12/month. The company has treated over 40,000 women cumulatively across roughly a decade of operation, has accumulated 1,000+ verified customer reviews with an average 4.5-star rating, and references 100,000+ users of its online assessment quiz. Clinical evidence supporting the platform includes randomized controlled trials showing 95% of women reporting fewer leaks and a 71% average reduction in leaks after six weeks of treatment. The company has raised approximately $6.4M+ across disclosed rounds, completed a Blu Venture Investors-led Series A in January 2024, and brought in additional capital in April 2026.

Name

Elidah

Legal name

Elidah Inc.

Website

https://elitone.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Elidah is a Connecticut-based medical device company that sells Elitone, an FDA-cleared external neuromuscular stimulation device for women with urinary incontinence. It markets directly to consumers via e-commerce, CVS retail, and Medicare Part B telehealth pathways, and has expanded into a men's post-prostatectomy product line.

Ownership category

akta.pro rank

Product category

Pelvic Floor Therapy Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Continence Care Products (Adult Incontinence Pads/Briefs, Underpads, External Collectors) (HLAHALAH)

akta.pro secondary industry

Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)

Keywords

• Pelvic floor therapy
• Urinary incontinence treatment
• Neuromuscular stimulation devices
• Women's health medical devices
• External pelvic floor stimulation

Headquarters

HQ city

Monroe

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Device Sales: One-time purchase of Elitone device (Starter Kit or Bundle) with GelPad packs included. Device is a reusable controller with disposable GelPads for ongoing treatment.
2. GelPad Consumables: Ongoing consumable sales of GelPads (reusable 3+ times) for maintenance mode treatment. GelPad packs of 5 available for $33.
3. Medicare Part B Billing: Direct billing to Medicare Part B for eligible patients with prescription. Patient co-pay typically around $150, potentially as low as $12/month through payment plans.
4. Distribution Partnership Revenue: Revenue from FEMSelect distribution partnership expanding Elitone availability through their women's health platform.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

Elidah develops, manufactures, and sells FDA-cleared external neuromuscular stimulation medical devices for treating urinary incontinence. Its flagship products—Elitone (stress incontinence), Elitone URGE (overactive bladder), and Elitone for Men (post-prostate surgery)—deliver proprietary Pre-Modulated Waveform stimulation through a patented perineal GelPad to strengthen pelvic floor muscles without invasive probes. Devices are sold direct-to-consumer via e-commerce and CVS, with Medicare Part B reimbursement available through a partnered telehealth provider.

Product overview

Elidah offers a portfolio of FDA-cleared external neuromuscular stimulation medical devices for treating urinary incontinence. The core products include Elitone (for stress incontinence), Elitone URGE (for urge/Overactive Bladder), and Elitone for Men (for post-prostate surgery recovery). All devices use a patented external GelPad technology that delivers stimulation through the skin to pelvic floor muscles. The portfolio is complemented by replacement GelPad consumables and accessories like cables and compression socks. Products are available over-the-counter or via Medicare prescription, with treatment typically involving 20 minutes daily for 6 weeks.

Differentiator

Problem solved

Functional benefit

Brands

• Elitone: FDA-cleared external pelvic floor therapy device for treatment of stress urinary incontinence in women. Delivers neuromuscular stimulation through the skin.
• Elitone URGE
• Elitone for Men
• GelPads

Products and services

• Elitone FDA-cleared external neuromuscular stimulation device for treating stress urinary incontinence in women. Worn externally on the perineal area for 20-minute daily sessions, it contracts pelvic floor muscles to reduce leaks associated with coughing, sneezing, or exercise. Sold OTC and via Medicare Part B.
• Elitone URGE FDA-cleared external neuromuscular stimulation device for treating urge urinary incontinence (Overactive Bladder) in women. Uses calming signals (6 sec calming signal + 6 sec rest cycle) to relax overactive bladder muscles, reducing sudden urges to urinate. Sold direct-to-consumer; not available outside the U.S.
• Elitone for Men FDA-cleared external neuromuscular stimulation device for men recovering bladder control after prostate surgery. Delivers neuromuscular stimulation to strengthen pelvic muscles, available over the counter and covered by Medicare.
• GelPads (Women) Replacement consumable hydrogel pads for Elitone and Elitone URGE devices. Patented low-tack hydrogel with four conductive regions, reusable at least 3 times, designed for comfortable skin contact over hair.
• GelPads (Men) Replacement consumable hydrogel pads specifically designed for the Elitone for Men device.
• Compression Socks Compression socks designed to reduce stress and support leg circulation for women dealing with incontinence-related lifestyle impacts.
• Cables Replacement cables for Elitone devices, included with both Elitone and Elitone URGE products.

Quantifiable outcome

• 95% of women reported fewer leaks after 6 weeks of treatment
• +4 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• FEMSelectcoreChannel Partner/ Reseller/ Distributor · 22 September 2025FEMSelect, a privately held women-led company focused on pelvic health, announced strategic partnership to distribute Elitone FDA-cleared medical devices. Partnership expands FEMSelect's portfolio beyond its EnPlace product for pelvic organ prolapse into the incontinence market. Follows FEMSelect's oversubscribed Series B financing and supports their growth strategy to build a comprehensive women's health solutions platform.
• MD IntegrationscoreImplementation/ SI/ Consulting PartnerLicensed telehealth provider partnership enabling prescription processing for Medicare and insurance coverage. MD Integrations provides online health questionnaire review by board-certified physicians. Consultation fee of $22 covers physician review. Most patients do not require scheduled video visits.
• CVS PharmacycoreChannel Partner/ Reseller/ DistributorRetail pharmacy partner for over-the-counter distribution of Elitone products. Products available in CVS Pharmacy locations alongside other health and wellness products.
• PayPalminorGTM or Marketing PartnerPayPal Pay Later financing option offering interest-free payments within 6 months for Elitone purchases. Enables affordable payment options for customers.
• AffirmminorGTM or Marketing PartnerMonthly payment plan provider offering multiple plan options for Elitone purchases. Interest may apply depending on plan selected. Quick approval process that does not affect credit score.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Atlantic Therapeutics: Maker of the INNOVO external pelvic floor stimulation shorts for stress urinary incontinence. Most directly comparable competitor to Elitone in the external NMES category for at-home incontinence treatment.
• Renovia: Developer of the Leva pelvic floor muscle training device for female stress urinary incontinence. Competes with Elitone in FDA-cleared, non-surgical, at-home pelvic floor therapy targeting the same female consumer.
• InControl Medical: Markets InTone and InToneMV devices that use neuromuscular stimulation to treat stress, urge, and mixed incontinence. Closely comparable FDA-cleared medical device competitor in the pelvic floor stimulation category.
• Elvie (Chiaro Technology): Consumer femtech brand offering the Elvie Trainer and Elvie Pump, with overlap into connected pelvic floor training. Comparable in DTC go-to-market, female consumer focus, and brand-led positioning, though Elvie is broader across women's health.
• Perifit: Connected pelvic floor trainer (Perifit Care) for at-home Kegel biofeedback and urinary incontinence. Competes with Elitone in DTC, app-connected pelvic floor therapy for the same female consumer segment.
• TensCare: Manufacturer of TENS/EMS devices including pelvic floor stimulators (e.g., iTouch Sure, Elise) sold across UK and Europe. Overlaps with Elitone in TENS/EMS technology platform and consumer-direct distribution of stimulation products.

Broad incumbents

• Axonics (Boston Scientific): Acquired by Boston Scientific, Axonics makes sacral neuromodulation (SNM) systems for urge incontinence and overactive bladder. A larger, well-capitalized competitor operating in the same therapy area through an implanted-device approach.
• Medtronic: Through InterStim, Medtronic is the established leader in sacral neuromodulation for urinary incontinence. Represents the dominant incumbent against which Elitone competes for share of voice and clinician adoption.
• Laborie Medical Technologies: Global urogynecology and pelvic health diagnostics/therapeutics company with a broad incontinence portfolio. Comparable as a larger incumbent operating across pelvic floor assessment and treatment, including stimulation-adjacent solutions.

Emerging players

• FEMSelect: Women-led pelvic health company behind the EnPlace pelvic organ prolapse device; strategic distribution partner for Elitone. Comparable as a focused women's pelvic health device company and overlapping commercial channel, though its core product targets prolapse rather than incontinence.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/elitondevice

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds6 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elidah